CID 91800165

Irbesartan metabolite 6

Structural Information

Molecular Formula
C25H26N6O2
SMILES
CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C25H26N6O2/c1-17(32)8-13-22-26-25(14-4-5-15-25)24(33)31(22)16-18-9-11-19(12-10-18)20-6-2-3-7-21(20)23-27-29-30-28-23/h2-3,6-7,9-12H,4-5,8,13-16H2,1H3,(H,27,28,29,30)
InChIKey
MIGTZGLTQNODIS-UHFFFAOYSA-N
Compound name
2-(3-oxobutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

442.21173 Da
Monoisotopic Mass

2.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 443.219006 204.4
[M+Na]+ 465.200948 210.7
[M-H]- 441.204454 211.7
[M+NH4]+ 460.245553 211.4
[M+K]+ 481.174888 203.7
[M+H-H2O]+ 425.208990 191.6
[M+HCOO]- 487.209931 217.3
[M+CH3COO]- 501.225581 211.2
[M+Na-2H]- 463.186396 198.3
[M]+ 442.21118142 202.5
[M]- 442.21227858 202.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.